Related references
Note: Only part of the references are listed.The Long Pentraxin PTX3 as a Link Between Innate Immunity, Tissue Remodeling, and Cancer
Andrea Doni et al.
FRONTIERS IN IMMUNOLOGY (2019)
Long pentraxin 3: A novel multifaceted player in cancer
Arianna Giacomini et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)
Paracrine interactions of cancer-associated fibroblasts, macrophages and endothelial cells: tumor allies and foes
Roberto Ronca et al.
CURRENT OPINION IN ONCOLOGY (2018)
Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth
Priscila Fabiana Rodrigues et al.
FRONTIERS IN ONCOLOGY (2018)
Clinical benefit of antiangiogenic therapy in advanced and metastatic chondrosarcoma
Robin L. Jones et al.
MEDICAL ONCOLOGY (2017)
Current diagnostics and treatment of fibrosarcoma -perspectives for future therapeutic targets and strategies
Daniela Augsburger et al.
ONCOTARGET (2017)
Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer
Roberto Ronca et al.
ONCOTARGET (2017)
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy
Roberto Ronca et al.
CANCER CELL (2015)
PTX3 Is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer
Eduardo Bonavita et al.
CELL (2015)
Mast cells and macrophages exert beneficial and detrimental effects on tumor progression and angiogenesis
Domenico Ribatti
IMMUNOLOGY LETTERS (2013)
Long pentraxin-3 as an epithelial-stromal fibroblast growth factor-targeting inhibitor in prostate cancer
Roberto Ronca et al.
JOURNAL OF PATHOLOGY (2013)
Long Pentraxin-3 Inhibits Epithelial-Mesenchymal Transition in Melanoma Cells
Roberto Ronca et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Long Pentraxin-3 Inhibits FGF8b-Dependent Angiogenesis and Growth of Steroid Hormone-Regulated Tumors
Daria Leali et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Fibroblast Growth Factor-2 Antagonist and Antiangiogenic Activity of Long-Pentraxin 3-Derived Synthetic Peptides
D. Leali et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Role of the soluble pattern recognition receptor PTX3 in vascular biology
Marco Presta et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2007)
Identification of an antiangiogenic FGF2-binding site in the N terminus of the soluble pattern recognition receptor PTX3
Maura Camozzi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Share Paper
